Reading Performance With a Video Magnifier

NCT ID: NCT01670643

Last Updated: 2017-03-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

120 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-01-31

Study Completion Date

2011-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The most common goal for patients with vision loss who present for vision rehabilitation is to be able to read. The video magnifier (a device which combines a video camera and a screen to view the print being magnified) is the device which most often allows low-vision individuals to read successfully for extended periods of time. Previous studies on the outcomes of vision rehabilitation have not identified which components of the vision rehabilitation are effective. The hypothesis of this project is that providing a video camera magnifier, with basic training in operating the device, will allow patients to enhance both objective reading ability and subjective report of reading competence.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients will be given a video magnifier at initial consultation or at the end of vision rehabilitation

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Macular Degeneration

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CROSSOVER

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Video camera magnifier

Video camera magnifier

Intervention Type BEHAVIORAL

reading with video camera magnifier

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Video camera magnifier

reading with video camera magnifier

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Optelec video magnifier

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Central field loss and decreased visual acuity in the better seeing eye (\<20/40 \& \>20/400).
* New patient at MEEI Low Vision Rehabilitation Clinic

Exclusion Criteria

* Dementia (Mini-Mental State Examination)
* Clinical depression (Geriatric Depression Scale)
* Patients who previously received vision rehabilitation
* Patients who have previously owned a desktop video magnifier
Minimum Eligible Age

40 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Mary Lou Jackson

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mary Lou Jackson

Principal Investigator

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mary Lou Jackson, MD

Role: PRINCIPAL_INVESTIGATOR

Vision Rehabilitation Center MEEI

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Vision Rehabilitation Clinic Massachusetts Eye and Ear Infirmary

Boston, Massachusetts, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

09-11-116

Identifier Type: OTHER

Identifier Source: secondary_id

09-11-116

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Q-Switched Nd:YAG in Macular Amyloidosis
NCT00353392 COMPLETED PHASE1